Last update 01 Nov 2024

IL15R x 4-1BBL

Basic Info

Related Targets
IL15R4-1BBL

Related

1
Drugs associated with IL15R x 4-1BBL
RTX-240
Target
4-1BBL x IL15R
Mechanism
4-1BBL inhibitors [+1]
Active Org.-
Originator Org.
Rubius Therapeutics, Inc.Rubius Therapeutics, Inc.
Active Indication-
Inactive Indication
Adult Acute Myeloblastic Leukemia [+1]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with IL15R x 4-1BBL
NCT04372706 / TerminatedPhase 1/2
Phase 1/2 Study of RTX-240 Monotherapy and in Combination With Pembrolizumab
100 Clinical Results associated with IL15R x 4-1BBL
Login to view more data
100 Translational Medicine associated with IL15R x 4-1BBL
Login to view more data
0 Patents (Medical) associated with IL15R x 4-1BBL
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free